Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development

Details for Australian Patent Application No. 2011239959 (hide)

Owner immatics biotechnologies GmbH

Inventors Weinschenk, Toni; Fritsche, Jens

Agent Pizzeys

Pub. Number AU-A-2011239959

PCT Pub. Number WO2011/128448

Priority 1006360.0 16.04.10 GB; 61/324,941 16.04.10 US

Filing date 15 April 2011

Wipo publication date 20 October 2011

International Classifications

G01N 33/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/128448 Priority application(s): WO2011/128448

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011239964-Method and apparatus for moulding parts made from composite materials

2011239946-Mixing device having a wear-resistant lining